Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lumbrokinase enteric-coated capsules plus aspirin for acute ischemic stroke
ChiCTR2000032952Phase 4Not yet recruiting
- Sponsor
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Start
- May 2020
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of lumbrokinase in ischemic stroke (2 arms), sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Primary endpoint: Modified Rankin Scale score. Planned start May 2020; status: not yet recruiting.
02
Drugs
lumbrokinase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR2000032952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000032952.